FIELD: medicine. SUBSTANCE: method involves additionally administering ximedon at a dose of 0.5 g three times a day during up to 20 days before and after surgical intervention as a part of other measures in medical care complex. EFFECT: enhanced effectiveness of treatment; prevented postoperative complications.
Title | Year | Author | Number |
---|---|---|---|
PREPARATION WITH SELECTIVE EFFECT AND METHOD FOR TREATMENT OF OSTEOARTHROSIS | 2001 |
|
RU2211037C1 |
PREPARATION FOR TREATMENT OF FREEZING PATIENTS | 1997 |
|
RU2157208C2 |
METHOD OF OBSTRUCTIVE JAUNDICE TREATMENT | 2006 |
|
RU2349322C2 |
METHOD FOR TREATING THE CASES OF NEUROTROPHIC NECROTIC TISSULAR DEFECTS | 2000 |
|
RU2197290C2 |
HEPATOPROTECTIVE AND DETOXICATING AGENT FOR TREATMENT AND PROPHYLAXIS OF COMPLICATIONS OF SUPPURATIVE-SEPTIC DISEASES | 2001 |
|
RU2195283C1 |
METHOD FOR PREDICTING ACUTE APPENDICITIS IN PREGNANT WOMEN | 2005 |
|
RU2293561C1 |
PREPARATION FOR TREATMENT OF SLUGGISH WOUND AND TROPHIC ULCER (VARIANTS) | 1998 |
|
RU2148989C1 |
METHOD FOR TREATING PURULENT-INFLAMMATORY DISEASES OF SKIN AND SUBCUTANEOUS FIBER | 2001 |
|
RU2217065C2 |
METHOD FOR TREATMENT OF PATIENTS SUFFERING FROM CHRONIC OSTEOMYELITIS | 1992 |
|
RU2073514C1 |
METHOD OF TREATMENT OF AUTOIMMUNE GENERAL DISEASES AND MEDICAL PRODUCT | 2007 |
|
RU2361588C2 |
Authors
Dates
2000-11-27—Published
1997-12-10—Filed